Varian nets CE Mark for Proton Therapy system
Varian Medical Systems has received European CE mark approval for its Proton Therapy system, designed to improve treatments and outcomes in cancer cases.

"The CE mark is an important milestone in Varian's initiative to develop and market a compact system capable of intensity-modulated proton therapy in single- or multi-room facilities," said Lester Boeh, Varian's vice president of emerging businesses.

The Palo Alto, Calif.-based company said the CE mark makes it possible for cancer treatment centers to begin ordering, installing and using its Proton Therapy System in regions where CE mark is required, without having to obtain a site-specific clearance to use the technology.

Through research and development, and the 2007 acquisition of Bergisch Gladbach, Germany-based Accel Instrument, Varian has developed a proton therapy system encompassing particle beam generation, treatment planning, imaging, motion management and information management technology.